Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Müller

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Cell Death and Differentiation|November 11, 2017
The oncolytic compound LTX-401 targets the Golgi apparatusHeng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Cell Reports. Medicine|December 20, 2023
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducersClara Savary, Léa Luciana, Paul Huchedé, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Cell Death and Differentiation|November 11, 2017
The oncolytic compound LTX-401 targets the Golgi apparatusHeng Zhou, Allan Sauvat, Lígia C Gomes-da-Silva, et al.
Cell Reports. Medicine|December 20, 2023
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducersClara Savary, Léa Luciana, Paul Huchedé, et al.
Pageof 2